BioLife Solutions, Inc. (NASDAQ:BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (CGT) and the broader biopharma markets, announced today an additional delay in the filing of its Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”).
Microsoft Azure Cloud Outage Disrupts Multiple Microsoft 365 Services Globally, Several users Affected
An outage of Microsoft Corp (NASDAQ:MSFT) Azure cloud services impacted multiple Microsoft 365 services, including Teams, Exchange Online, Outlook, SharePoint…
